STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #131 by analyst upside · 2026-08-12
CBUS
Cibus, Inc.
Healthcare · Market Cap $154M · P/E 0x
ANALYST PRICE TARGET
+671.9%
implied upside to consensus target
Current Price $1.9
Consensus Target $14.67
Bull Target $25.0
Bear Target $3.0
Analysts Covering 3
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
2
Hold
1
Sell
0
52-Week Low $1.09
52-Week High $4.19
YTD Return +1.1%
FUNDAMENTALS
Market Cap $154M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.77
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $4M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $1.09
52-Week High $4.19
Current Price $1.9
Bear Target $3.0
Bull Target $25.0
● Now $1.9 ● Target $14.67
TRADING DATA
Avg Volume 319K
YTD Return +1.1%
Analyst Count 3
Consensus Buy
Upside to Target +671.9%
Last Updated 2026-08-12

ANALYST SUMMARY

Cibus, Inc. (CBUS) is currently trading at $1.9 with a Wall Street consensus price target of $14.67, implying potential upside of 671.9% over the next 12 months. 3 analysts currently cover CBUS, with a consensus rating of Buy - 67% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $25.0, while the most cautious has a target of $3.0.

CBUS operates in the Healthcare sector with a market capitalisation of $154M. The stock is up 1.1% year-to-date and is currently trading near the lower end of its 52-week range of $1.09 – $4.19.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CBUS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Jefferies - Reiterated
Hold → Hold 2026-03-25 50% win rate (6 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2025-12-08 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2025-05-12 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-03-21 31% win rate (48 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2025-01-22 Building track record
HC Wainwright & Co. reit
Buy → Buy 2024-11-11 31% win rate (48 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2024-10-22 Building track record
Alliance Global Partners - Reiterated
Buy → Buy 2024-09-24 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
25
out of 100
Coverage depth
11/30
Consensus clarity
0/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →